MétaCan
Menu
Back to cohort
Record W4367017601 · doi:10.1021/cen-09924-cover3

A long collaboration arrives at production

2021· article· en· W4367017601 on OpenAlexaboutno aff
special to C EN Vanessa Zainzinger

Bibliographic record

VenueC&EN Global Enterprise · 2021
Typearticle
Languageen
FieldMedicine
TopicBiotechnology and Related Fields
Canadian institutionsnot available
Fundersnot available
KeywordsProduction (economics)BusinessEconomics

Abstract

fetched live from OpenAlex

On Friday, Jan. 22, at around 3:00 p.m. on the US West Coast, Robert Huizinga celebrated a milestone. He received word that the US Food and Drug Administration had approved voclosporin, a drug developed by Aurinia Pharmaceuticals for the treatment of adults with lupus nephritis. To Huizinga, Aurinia’s executive vice president of research, the FDA approval was the culmination of more than 15 years of work. “It was immensely gratifying,” he recalls. “I will remember that day for the rest of my life.” Voclosporin was discovered in the mid-1990s at Isotechnika Pharma, which merged with the Canadian biotech firm Aurinia in 2013 and took the firm’s name. Huizinga led the clinical development program for voclosporin before and after the acquisition—including a shift in the synthesis from one that yielded racemates to one that yields a single trans isomer. The result was the first FDA-approved oral therapy for lupus nephritis. Now

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.012
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: Other
Teacher disagreement score0.389
Threshold uncertainty score0.872

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0050.012
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.002
Science and technology studies0.0120.003
Scholarly communication0.0240.012
Open science0.0020.009
Research integrity0.0070.010
Insufficient payload (model declined to judge)0.3890.306

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.258
Teacher spread0.254 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueC&EN Global EnterpriseSame topicBiotechnology and Related FieldsFrench-language works237,207